Patent Assignment
Reel/Frame 060979/0247
Assignment of Assignor's Interest
Recorded: 2022-09-02
Pages: 4
Assignor
BIODURO LLC
Executed: 2019-04-27
Assignee
SHIRE HUMAN GENETIC THERAPIES, INC.
300 SHIRE WAY, LEXINGTON, MASSACHUSETTS, 02421
Covered Property
(1)
Inhibitors of Plasma Kallikrein and Uses Thereof
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 2, 2022
From: FINK, SARAH JOCELYN
To: BIODURO LLC
Reel/Frame 060979/0113 →
Assignment of Assignor's Interest
Sep 2, 2022
From: RAE, ALASTAIR; ELLARD, JOHN MARK
To: CHARLES RIVER DISCOVERY RESEARCH SERVICES UK LIMITED
Reel/Frame 060979/0188 →
Assignment of Assignor's Interest
Sep 2, 2022
From: PAPAIOANNOU, NIKOLAOS; MILLER, THOMAS ALLEN; SHIPPS, GERALD WAYNE, JR.; TRAVINS, JEREMY MARK
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 060979/0211 →
Assignment of Assignor's Interest
Sep 2, 2022
From: CHARLES RIVER DISCOVERY RESEARCH SERVICES UK LIMITED
To: CHARLES RIVER LABORATORIES, INC.
Reel/Frame 060979/0293 →
Assignment of Assignor's Interest
Sep 2, 2022
From: SHIRE HUMAN GENETIC THERAPIES, INC.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 060979/0299 →
Assignment of Assignor's Interest
Sep 2, 2022
From: CHARLES RIVER LABORATORIES, INC.
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 060979/0360 →